Defitelio and Escherichia infection - a phase IV clinical study of FDA data
Escherichia infection is found among people who take Defitelio, especially for people who are female, 40-49 old, have been taking the drug for < 1 month.
The phase IV clinical study analyzes which people take Defitelio and have Escherichia infection. It is created by eHealthMe based on reports of 3,105 people who have side effects when taking Defitelio from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
3,105 people reported to have side effects when taking Defitelio.
Among them, 11 people (0.35%) have Escherichia infection.
What is Defitelio?
Defitelio has active ingredients of defibrotide sodium. eHealthMe is studying from 2,995 Defitelio users for its effectiveness, alternative drugs and more.
What is Escherichia infection?
Escherichia infection (bacterial infection by escherichia coli) is found to be associated with 1,233 drugs and 791 conditions by eHealthMe.
Number of Defitelio and Escherichia infection reports submitted per year:
Time on Defitelio when people have Escherichia infection *:
- < 1 month: 100 %
- 1 - 6 months: 0.0 %
- 6 - 12 months: 0.0 %
- 1 - 2 years: 0.0 %
- 2 - 5 years: 0.0 %
- 5 - 10 years: 0.0 %
- 10+ years: 0.0 %
Gender of people who have Escherichia infection when taking Defitelio *:
- female: 75 %
- male: 25 %
Age of people who have Escherichia infection when taking Defitelio *:
- 0-1: 0.0 %
- 2-9: 25 %
- 10-19: 0.0 %
- 20-29: 25 %
- 30-39: 0.0 %
- 40-49: 50 %
- 50-59: 0.0 %
- 60+: 0.0 %
Common drugs people take besides Defitelio *:
- Ondansetron: 2 people, 18.18%
- Tramadol: 2 people, 18.18%
- Pantoprazole: 2 people, 18.18%
- Methylprednisolone: 2 people, 18.18%
- Neoral: 2 people, 18.18%
- Bactrim: 2 people, 18.18%
- Cyclosporine: 1 person, 9.09%
- Enbrel: 1 person, 9.09%
- Esomeprazole Magnesium: 1 person, 9.09%
- Noxafil: 1 person, 9.09%
Common side effects people have besides Escherichia infection *:
- Graft Versus Host Disease (the donated bone marrow or stem cells view the recipient's body as foreign, and the donated cells/bone marrow attack the body): 3 people, 27.27%
- Acute Myeloid Leukaemia Recurrent (acute cancer in which the bone marrow makes abnormal myeloblast- recurrent): 3 people, 27.27%
- Septic Shock (shock due to blood infection): 3 people, 27.27%
- Sepsis (a severe blood infection that can lead to organ failure and death): 2 people, 18.18%
- Bronchospasm (spasm of bronchial smooth muscle producing narrowing of the bronchi): 1 person, 9.09%
- Epstein-Barr Virus Infection: 1 person, 9.09%
- Enterococcal Infection: 1 person, 9.09%
- Enterobacter Infection (infection caused by bacteria of the family enterobacteriaceae): 1 person, 9.09%
- Cough: 1 person, 9.09%
- Chronic Graft Versus Host Disease (immune cells attack the host's body cells after transplant): 1 person, 9.09%
Common conditions people have *:
- Venoocclusive Disease (small veins in the liver are obstructed): 5 people, 45.45%
- Pain: 3 people, 27.27%
- Cytomegalovirus Infection: 2 people, 18.18%
- Gastric Disorder (disease of stomach): 2 people, 18.18%
- Nausea And Vomiting: 2 people, 18.18%
- Graft Versus Host Disease (the donated bone marrow or stem cells view the recipient's body as foreign, and the donated cells/bone marrow attack the body): 2 people, 18.18%
- Venoocclusive Liver Disease (small veins in the liver are obstructed): 1 person, 9.09%
- Hepatitis (inflammation of the liver): 1 person, 9.09%
- Depression: 1 person, 9.09%
- Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 1 person, 9.09%
* Approximation only. Some reports may have incomplete information.
Do you take Defitelio and have Escherichia infection?Check whether Escherichia infection is associated with a drug or a condition
How to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
How severe was Escherichia infection and when was it recovered:
Expand to all the drugs that have ingredients of defibrotide sodium:
Alternative drugs to, pros and cons of Defitelio:
- Defitelio (2,995 reports)
Common Defitelio side effects:
Browse all side effects of Defitelio:a b c d e f g h i j k l m n o p q r s t u v w x y z
Escherichia infection treatments and more:
- Escherichia infection (8,441 reports)
COVID vaccines that are related to Escherichia infection:
- Escherichia infection in Moderna COVID Vaccine
- Escherichia infection in Pfizer BioNTech Covid Vaccine
- Escherichia infection in Johnson and Johnson Covid Vaccine
Common drugs associated with Escherichia infection:
All the drugs that are associated with Escherichia infection:
- Escherichia infection (1,233 drugs)
Common conditions associated with Escherichia infection:
All the conditions that are associated with Escherichia infection:
- Escherichia infection (791 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on defibrotide sodium (the active ingredients of Defitelio) and Defitelio (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Gemcitabine and Catheter Site Infection - 3 seconds ago
- Sandostatin and Administration Site Pain - 9 seconds ago
- Nipride and Valsartan drug interaction - 11 seconds ago
- Altace and Avandia drug interaction - 13 seconds ago
- Zyrtec and Methenamine Hippurate drug interaction - 21 seconds ago
- Xyrem and Allegra D 24 Hour drug interaction - 21 seconds ago
- Forteo and Simvastatin drug interaction - 24 seconds ago
- Gastritis Aggravated and Chagas Disease - 29 seconds ago
- Hormone Replacement Therapy and Hair Color Changes - 35 seconds ago
- Cefuroxime Axetil and Byetta drug interaction - 43 seconds ago